Antibiotics Market Research Report by Drug Class (Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, and Macrolides), by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antibiotics Market is expected to grow from USD 35,189.41 Million in 2020 to USD 47,947.29 Million by the end of 2025.
2. The Global Antibiotics Market is expected to grow from EUR 30,854.74 Million in 2020 to EUR 42,041.09 Million by the end of 2025.
3. The Global Antibiotics Market is expected to grow from GBP 27,429.93 Million in 2020 to GBP 37,374.62 Million by the end of 2025.
4. The Global Antibiotics Market is expected to grow from JPY 3,755,601.74 Million in 2020 to JPY 5,117,190.82 Million by the end of 2025.
5. The Global Antibiotics Market is expected to grow from AUD 51,099.70 Million in 2020 to AUD 69,625.84 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Antibiotics Market studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
Based on Action Mechanism, the Antibiotics Market studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
Based on Geography, the Antibiotics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibiotics Market including Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, Bristol Myers Squibb Company, Cadila Healthcare Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Johnson & Johnson Services, Inc, KYORIN Holdings, Inc, LG Chem Ltd, Lupin Limited, Melinta Therapeutics, Inc, Merck & Co., Inc, MerLion Pharmaceuticals GmbH, Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi S.A, Shionogi & Company, Limited, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibiotics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antibiotics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?
4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?
5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antibiotics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antibiotics Market is expected to grow from USD 35,189.41 Million in 2020 to USD 47,947.29 Million by the end of 2025.
2. The Global Antibiotics Market is expected to grow from EUR 30,854.74 Million in 2020 to EUR 42,041.09 Million by the end of 2025.
3. The Global Antibiotics Market is expected to grow from GBP 27,429.93 Million in 2020 to GBP 37,374.62 Million by the end of 2025.
4. The Global Antibiotics Market is expected to grow from JPY 3,755,601.74 Million in 2020 to JPY 5,117,190.82 Million by the end of 2025.
5. The Global Antibiotics Market is expected to grow from AUD 51,099.70 Million in 2020 to AUD 69,625.84 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Antibiotics Market studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
Based on Action Mechanism, the Antibiotics Market studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
Based on Geography, the Antibiotics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibiotics Market including Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, Bristol Myers Squibb Company, Cadila Healthcare Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Johnson & Johnson Services, Inc, KYORIN Holdings, Inc, LG Chem Ltd, Lupin Limited, Melinta Therapeutics, Inc, Merck & Co., Inc, MerLion Pharmaceuticals GmbH, Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi S.A, Shionogi & Company, Limited, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibiotics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antibiotics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?
4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?
5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antibiotics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Action Mechanism Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of patients suffering from infectious diseases
5.1.1.2. Development of novel strategies for new antibiotics and a large number of clinical trials
5.1.1.3. Extended consumption in low and middle-income countries
5.1.2. Restraints
5.1.2.1. Misuse of antibiotics
5.1.3. Opportunities
5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
5.1.3.2. Growing in R&D of new drugs
5.1.4. Challenges
5.1.4.1. Side effects caused by the usage of antibiotic drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTIBIOTICS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Aminoglycosides
6.3. Carbapenem
6.4. Cephalosporin
6.5. Fluoroquinolone
6.6. Macrolides
6.7. Penicillin
6.8. Sulfonamides
7. GLOBAL ANTIBIOTICS MARKET, BY ACTION MECHANISM
7.1. Introduction
7.2. Cell Wall Synthesis Inhibitors
7.3. DNA Synthesis Inhibitors
7.4. Mycolic Acid Inhibitors
7.5. Protein Synthesis Inhibitors
7.6. RNA Synthesis Inhibitors
8. AMERICAS ANTIBIOTICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ANTIBIOTICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Akron Incorporated
12.3. Amneal Pharmaceuticals LLC
12.4. Astellas Pharma, Inc.
12.5. AstraZeneca PLC
12.6. Bausch Health Companies Inc
12.7. Bayer AG
12.8. Bristol Myers Squibb Company
12.9. Cadila Healthcare Limited
12.10. Eli Lilly and Company
12.11. F. Hoffmann-La Roche Ltd
12.12. GlaxoSmithKline PLC
12.13. Janssen Pharmaceuticals
12.14. Johnson & Johnson Services, Inc
12.15. KYORIN Holdings, Inc
12.16. LG Chem Ltd
12.17. Lupin Limited
12.18. Melinta Therapeutics, Inc
12.19. Merck & Co., Inc
12.20. MerLion Pharmaceuticals GmbH
12.21. Mylan N.V.
12.22. Novartis AG
12.23. Pfizer, Inc.
12.24. Sanofi S.A
12.25. Shionogi & Company, Limited
12.26. Sun Pharmaceutical Industries Limited
12.27. Teva Pharmaceutical Industries Ltd
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Action Mechanism Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of patients suffering from infectious diseases
5.1.1.2. Development of novel strategies for new antibiotics and a large number of clinical trials
5.1.1.3. Extended consumption in low and middle-income countries
5.1.2. Restraints
5.1.2.1. Misuse of antibiotics
5.1.3. Opportunities
5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
5.1.3.2. Growing in R&D of new drugs
5.1.4. Challenges
5.1.4.1. Side effects caused by the usage of antibiotic drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTIBIOTICS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Aminoglycosides
6.3. Carbapenem
6.4. Cephalosporin
6.5. Fluoroquinolone
6.6. Macrolides
6.7. Penicillin
6.8. Sulfonamides
7. GLOBAL ANTIBIOTICS MARKET, BY ACTION MECHANISM
7.1. Introduction
7.2. Cell Wall Synthesis Inhibitors
7.3. DNA Synthesis Inhibitors
7.4. Mycolic Acid Inhibitors
7.5. Protein Synthesis Inhibitors
7.6. RNA Synthesis Inhibitors
8. AMERICAS ANTIBIOTICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ANTIBIOTICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Akron Incorporated
12.3. Amneal Pharmaceuticals LLC
12.4. Astellas Pharma, Inc.
12.5. AstraZeneca PLC
12.6. Bausch Health Companies Inc
12.7. Bayer AG
12.8. Bristol Myers Squibb Company
12.9. Cadila Healthcare Limited
12.10. Eli Lilly and Company
12.11. F. Hoffmann-La Roche Ltd
12.12. GlaxoSmithKline PLC
12.13. Janssen Pharmaceuticals
12.14. Johnson & Johnson Services, Inc
12.15. KYORIN Holdings, Inc
12.16. LG Chem Ltd
12.17. Lupin Limited
12.18. Melinta Therapeutics, Inc
12.19. Merck & Co., Inc
12.20. MerLion Pharmaceuticals GmbH
12.21. Mylan N.V.
12.22. Novartis AG
12.23. Pfizer, Inc.
12.24. Sanofi S.A
12.25. Shionogi & Company, Limited
12.26. Sun Pharmaceutical Industries Limited
12.27. Teva Pharmaceutical Industries Ltd
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GLOBAL ANTIBIOTICS MARKET: SCORES
TABLE 78. GLOBAL ANTIBIOTICS MARKET: BUSINESS STRATEGY
TABLE 79. GLOBAL ANTIBIOTICS MARKET: PRODUCT SATISFACTION
TABLE 80. GLOBAL ANTIBIOTICS MARKET: RANKING
TABLE 81. GLOBAL ANTIBIOTICS MARKET: MERGER & ACQUISITION
TABLE 82. GLOBAL ANTIBIOTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 83. GLOBAL ANTIBIOTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 84. GLOBAL ANTIBIOTICS MARKET: INVESTMENT & FUNDING
TABLE 85. GLOBAL ANTIBIOTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 86. GLOBAL ANTIBIOTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GLOBAL ANTIBIOTICS MARKET: SCORES
TABLE 78. GLOBAL ANTIBIOTICS MARKET: BUSINESS STRATEGY
TABLE 79. GLOBAL ANTIBIOTICS MARKET: PRODUCT SATISFACTION
TABLE 80. GLOBAL ANTIBIOTICS MARKET: RANKING
TABLE 81. GLOBAL ANTIBIOTICS MARKET: MERGER & ACQUISITION
TABLE 82. GLOBAL ANTIBIOTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 83. GLOBAL ANTIBIOTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 84. GLOBAL ANTIBIOTICS MARKET: INVESTMENT & FUNDING
TABLE 85. GLOBAL ANTIBIOTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 86. GLOBAL ANTIBIOTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANTIBIOTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBIOTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ANTIBIOTICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ANTIBIOTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (%)
FIGURE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2025
FIGURE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 31. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. ARGENTINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. BRAZIL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CANADA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. MEXICO ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CHINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDONESIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. JAPAN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MALAYSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. FRANCE ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. GERMANY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. ITALY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. QATAR ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. RUSSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SPAIN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 67. GLOBAL ANTIBIOTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBIOTICS MARKET, BY TYPE
FIGURE 1. GLOBAL ANTIBIOTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBIOTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ANTIBIOTICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ANTIBIOTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (%)
FIGURE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2025
FIGURE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 31. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 32. AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 34. ARGENTINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. BRAZIL ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CANADA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. MEXICO ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CHINA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDONESIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. JAPAN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MALAYSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. THAILAND ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. FRANCE ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. GERMANY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. ITALY ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. QATAR ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. RUSSIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SPAIN ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL ANTIBIOTICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 67. GLOBAL ANTIBIOTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBIOTICS MARKET, BY TYPE
